BCEL:Cl A Com/Atreca Inc - Stock Price Quote and Dividend Data
BCEL STOCK PRICE LATEST CLOSE
$0.09
EXCHANGE
OTCBB
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
Cl A Com/Atreca Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Cl A Com/Atreca Inc Stock Price Information
52-Week Low/High Stock Price$0.07 - $0.10
Percent Held by Institutions31.17%
Revenue$0
Net Income$-133,971,000
Cash Flow$-64,309,000
EPS-0.92%
Market Cap$2,932,200
PE Ratio0
PE Ratio to Industry114%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months0.00%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateJun. 14, 2024
Cl A Com/Atreca Inc Annual Stock Dividends
No Data available for Payment History.
Cl A Com/Atreca Inc Dividend Payment History
| No dividends retrieved for BCEL |
Cl A Com/Atreca Inc Other Dividend Details
Atreca is a clinical-stage biopharmaceutical company utilizing its platform primarily to discover and develop antibody-based immunotherapeutics to treat a range of solid tumor types. Co.'s primary product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. ATRC-101 reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal and breast cancer samples from multiple patients. Co. owns worldwide rights to ATRC-101.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
May. 29, 2024BCEL STOCK PRICE INCREASE: Cl A Com/Atreca Inc on 05-29-2024 increased stock price > 10% from $0.09 to $0.10
Apr. 30, 2024BCEL STOCK PRICE INCREASE: Cl A Com/Atreca Inc on 04-30-2024 increased stock price > 10% from $0.08 to $0.09
Apr. 23, 2024BCEL STOCK PRICE INCREASE: Cl A Com/Atreca Inc on 04-23-2024 increased stock price > 10% from $0.08 to $0.09
Apr. 09, 2024BCEL STOCK PRICE INCREASE: Cl A Com/Atreca Inc on 04-09-2024 increased stock price > 10% from $0.07 to $0.08
Mar. 27, 2024BCEL STOCK PRICE INCREASE: Cl A Com/Atreca Inc on 03-27-2024 increased stock price > 10% from $0.07 to $0.08
Mar. 22, 2024BCEL STOCK PRICE INCREASE: Cl A Com/Atreca Inc on 03-22-2024 increased stock price > 10% from $0.06 to $0.08
Mar. 21, 2024BCEL STOCK PRICE DECREASE: Cl A Com/Atreca Inc on 03-21-2024 decreased stock price > 10% from $0.15 to $0.06
Mar. 19, 2024BCEL STOCK PRICE DECREASE: Cl A Com/Atreca Inc on 03-19-2024 decreased stock price > 10% from $0.17 to $0.15
Mar. 16, 2024BCEL STOCK PRICE DECREASE: Cl A Com/Atreca Inc on 03-16-2024 decreased stock price > 10% from $0.20 to $0.17
Mar. 14, 2024BCEL STOCK PRICE INCREASE: Cl A Com/Atreca Inc on 03-14-2024 increased stock price > 10% from $0.17 to $0.19
Apr. 09, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-09-2025 decreased stock price > 10% from $0.40 to $0.27
Apr. 09, 2025MAZE STOCK PRICE DECREASE: Maze Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $8.92 to $7.57
Apr. 09, 2025KANT STOCK PRICE DECREASE: Kineta Inc on 04-09-2025 decreased stock price > 10% from $0.35 to $0.30
Apr. 09, 2025ORKA STOCK PRICE DECREASE: Oruka Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $7.62 to $6.78
Apr. 09, 2025XCUR STOCK PRICE DECREASE: Com Par $0.0001/Exicure Inc on 04-09-2025 decreased stock price > 10% from $12.80 to $11.39
Apr. 09, 2025BIVI STOCK PRICE DECREASE: Cl A Par $0.0001/BioVie Inc on 04-09-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 09, 2025ARTV STOCK PRICE DECREASE: Artiva Biotherapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.31 to $1.92
Apr. 09, 2025ENTO STOCK PRICE DECREASE: Com Par $0.0001 (New)/Entero Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.49 to $0.42
Apr. 09, 2025APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 04-09-2025 decreased stock price > 10% from $1.30 to $1.13
Apr. 09, 2025RKVTF STOCK PRICE DECREASE: Rakovina Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.06 to $0.05
